Contact this trialFirst, we need to learn more about you.
IDH Inhibitor
AG-120 or AG-221 Combination Therapy for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
New York, New York
This trial is studying AG-120 and AG-221 to see if they are safe when given with standard AML induction and consolidation therapy and to find the maximum tolerated dose of each drug.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service